Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 29, 2002

View Archived Issues

Company Profile: Entomed

U.S. launch of Paremyd scheduled for March

Aricept associated with significant benefits in the treatment of vascular dementia

Forest receives approvable letter for Lexapro in major depressive disorder

Iressa under regulatory review in two major markets for NSCLC

Phase IIb results reported for OvaRex in metastatic ovarian cancer

Argenta Discovery and Lundbeck collaborate on CNS program

Synt:em collaborates with Baxter to develop monoclonal antibody mimetics

Novirio research consortium receives grant for antiflavivirus drug candidate development

Schering AG and Mologen to develop cell-based therapies

First Plantibodies candidate heads for clinical testing

Chemokine CCR1 receptor antagonist effective in mouse model of renal fibrosis

Preparation and use of new series of PDE5 inhibitors

Acylphenylurea derivatives effective as inhibitors of glycogen phosphorylase according to Aventis

Novel caspase inhibitors identified at Vertex

Pfizer team synthesizes selective adenosine A2A receptor agonists

Benzamide-containing compounds that act as ligands of thyroid hormone receptor beta

Preparation and use of purine derivatives with antiviral activity claimed

Rituximab + CHOP as a new drug combination for aggressive NHL

TKT's Fabry's disease enzyme replacement therapy available for use in E.U.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...